Header Logo

Connection

QIANG TONG to Cell Line, Tumor

Back to Details
This is a "connection" page, showing publications QIANG TONG has written about Cell Line, Tumor.
QIANG TONG
Connection Strength
1.617
Cell Line, Tumor
  1. Dual targeting of AMRC12 and Malassezia globosa disrupts MYC liquid condensates-driven nuclear pore complex biogenesis in neuroblastoma. Theranostics. 2026; 16(6):2866-2886.
    View in: PubMed
    Score: 0.143
  2. YY1 drives PARP1 expression essential for PARylation of NONO in mRNA maturation during neuroblastoma progression. J Transl Med. 2024 Dec 27; 22(1):1153.
    View in: PubMed
    Score: 0.133
  3. A size-switchable nanocluster remodels the immunosuppressive microenvironment of tumor and tumor-draining lymph nodes for improved cancer immunotherapy. Biomaterials. 2025 Apr; 315:122910.
    View in: PubMed
    Score: 0.131
  4. Targeting c-Myc transactivation by LMNA inhibits tRNA processing essential for malate-aspartate shuttle and tumour progression. Clin Transl Med. 2024 05; 14(5):e1680.
    View in: PubMed
    Score: 0.127
  5. Therapeutic targeting of FUBP3 phase separation by GATA2-AS1 inhibits malate-aspartate shuttle and neuroblastoma progression via modulating SUZ12 activity. Oncogene. 2023 09; 42(36):2673-2687.
    View in: PubMed
    Score: 0.121
  6. A Tumor-Penetrating Nanomedicine Improves the Chemoimmunotherapy of Pancreatic Cancer. Small. 2021 07; 17(29):e2101208.
    View in: PubMed
    Score: 0.104
  7. HNF4A-AS1/hnRNPU/CTCF axis as a therapeutic target for aerobic glycolysis and neuroblastoma progression. J Hematol Oncol. 2020 03 26; 13(1):24.
    View in: PubMed
    Score: 0.096
  8. Helicobacter pylori Infection Facilitates the Expression of Resistin-like Molecule Beta in Gastric Carcinoma and Precursor Lesions. Curr Med Sci. 2020 Feb; 40(1):95-103.
    View in: PubMed
    Score: 0.095
  9. Long Noncoding RNA NHEG1 Drives ?-Catenin Transactivation and Neuroblastoma Progression through Interacting with DDX5. Mol Ther. 2020 03 04; 28(3):946-962.
    View in: PubMed
    Score: 0.094
  10. Therapeutic targeting of YY1/MZF1 axis by MZF1-uPEP inhibits aerobic glycolysis and neuroblastoma progression. Theranostics. 2020; 10(4):1555-1571.
    View in: PubMed
    Score: 0.094
  11. Circ-HuR suppresses HuR expression and gastric cancer progression by inhibiting CNBP transactivation. Mol Cancer. 2019 11 13; 18(1):158.
    View in: PubMed
    Score: 0.093
  12. Nortriptyline Inhibits Lysosomal Exocytosis-Mediated SASP During Gastric Cancer Progression via Targeting HOXA1-PITX2 Phase Separation. Adv Sci (Weinh). 2025 Dec; 12(46):e12407.
    View in: PubMed
    Score: 0.035
  13. Targeting RBM10-Repressed RORB Activity in Liquid Condensates Inhibits Lysosomal Biogenesis and Neuroblastoma Progression via Affecting NF-?B Signaling. Adv Sci (Weinh). 2025 Nov; 12(44):e06131.
    View in: PubMed
    Score: 0.035
  14. Tumor pH-triggered PEG detachable nanoparticles for TLR7/8 agonist delivery to improve cancer immunotherapy. Biomater Sci. 2025 May 13; 13(10):2794-2805.
    View in: PubMed
    Score: 0.034
  15. Phagocytosis-Activating Nanocomplex Orchestrates Macrophage-Mediated Cancer Immunotherapy. Adv Mater. 2025 Jul; 37(28):e2500982.
    View in: PubMed
    Score: 0.034
  16. SNORA37/CMTR1/ELAVL1 feedback loop drives gastric cancer progression via facilitating?CD44 alternative splicing. J Exp Clin Cancer Res. 2025 Jan 16; 44(1):15.
    View in: PubMed
    Score: 0.033
  17. Self-Assembled Nanoparticles from the Amphiphilic Prodrug of Resiquimod for Improved Cancer Immunotherapy. ACS Appl Mater Interfaces. 2024 May 22; 16(20):25665-25675.
    View in: PubMed
    Score: 0.032
  18. circ-hnRNPU inhibits NONO-mediated c-Myc transactivation and mRNA stabilization essential for glycosylation and cancer progression. J Exp Clin Cancer Res. 2023 Nov 23; 42(1):313.
    View in: PubMed
    Score: 0.031
  19. Precision medicine-guided co-delivery of ASPN siRNA and oxaliplatin by nanoparticles to overcome chemoresistance of colorectal cancer. Biomaterials. 2022 11; 290:121827.
    View in: PubMed
    Score: 0.028
  20. Downregulation of hsa_circ_0074854 Suppresses the Migration and Invasion in Hepatocellular Carcinoma via Interacting with HuR and via Suppressing Exosomes-Mediated Macrophage M2 Polarization. Int J Nanomedicine. 2021; 16:2803-2818.
    View in: PubMed
    Score: 0.026
  21. Myeloma cells shift osteoblastogenesis to adipogenesis by inhibiting the ubiquitin ligase MURF1 in mesenchymal stem cells. Sci Signal. 2020 05 26; 13(633).
    View in: PubMed
    Score: 0.024
  22. Nanoenabled Reversal of IDO1-Mediated Immunosuppression Synergizes with Immunogenic Chemotherapy for Improved Cancer Therapy. Nano Lett. 2019 08 14; 19(8):5356-5365.
    View in: PubMed
    Score: 0.023
  23. Reprogrammed marrow adipocytes contribute to myeloma-induced bone disease. Sci Transl Med. 2019 05 29; 11(494).
    View in: PubMed
    Score: 0.023
  24. Mature adipocytes in bone marrow protect myeloma cells against chemotherapy through autophagy activation. Oncotarget. 2015 Oct 27; 6(33):34329-41.
    View in: PubMed
    Score: 0.018
  25. The transcription factor GATA2 regulates differentiation of brown adipocytes. EMBO Rep. 2005 Sep; 6(9):879-84.
    View in: PubMed
    Score: 0.009
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.